Investigational drug · Phase 2
SRSD384
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Overweight , Obesity.
Phase 2Last checked: Nov 19, 2026Latest source record: Jun 5, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
1
Any phase or sponsor naming "SRSD384"
First trial start
2026
Jun 2026
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "SRSD384", any sponsor or status.
Conditions studied
As listed on its trial records.
- Overweight , Obesity
Approved drugs for the same conditions: Obesity and weight management · Cardiovascular and metabolic
Largest trials
Live from ClinicalTrials.gov: studies naming "SRSD384" as an intervention, largest first.
- A Study of SRSD384 in Overweight or Obese ParticipantsNot yet recruiting
Sirius Therapeutics Co., Ltd.Industry
NCT07557355 · 78 participants (planned) · Start Jun 2026 · Primary completion Oct 2027
Drug: SRSD384 injection; Placebo · For: Overweight , Obesity
Sites: Charlestown, Australia
Newest research
PubMed records naming it or its code names, newest first.
No PubMed records name it yet, which is common for early code-named drugs.
Also in development for Overweight , Obesity
- EcnoglutideXW003, VRB-101Phase 38 trials
Hangzhou Sciwind Biosciences Co., Ltd. · Obesity, Weight Management, OSA - Obstructive Sleep Apnea
- MWN109 1Phase 36 trials
Shanghai Minwei Biotechnology Co., Ltd · Overweight , Obesity, Type 2 Diabetes Mellitus (T2DM)
- MWN109 2Phase 36 trials
Shanghai Minwei Biotechnology Co., Ltd · Overweight , Obesity, Type 2 Diabetes Mellitus (T2DM)
- MWN109 3Phase 35 trials
Shanghai Minwei Biotechnology Co., Ltd · Overweight , Obesity, Type 2 Diabetes Mellitus (T2DM)
- zovaglutideZT002Phase 33 trials
Beijing QL Biopharmaceutical Co.,Ltd · Obesity, Overweight , Obesity, Overweight or Obesity
- matching dosagePhase 22 trials
Hangzhou Sciwind Biosciences Co., Ltd. · Weight Management, Overweight , Obesity, Overweight and/or Obesity
- MWN109 4Phase 22 trials
Shanghai Minwei Biotechnology Co., Ltd · Type 2 Diabetes Mellitus (T2DM), Overweight , Obesity
- ALV-100Phase 21 trial
Alveus Therapeutics, Inc. · Overweight , Obesity, Adults
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.